Low dose of emetine as potential anti-SARS-CoV-2 virus therapy: preclinical in vitro inhibition and in vivo pharmacokinetic evidences

The global pandemic of COVID-19 has attracted extensive drug searching interets for the new coronavirus SARS-CoV-2. Although currently several of clinically used “old” drugs have been repurposed to this new disease for the urgent clinical investigation, there is still great demand for more effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Aoli, Sun, Yong, Liu, Qingwang, Wu, Hong, Liu, Juan, He, Jun, Yu, Junling, Chen, Qing Qing, Ge, Yinglu, Zhang, Zhuhui, Hu, Chen, Chen, Cheng, Qi, Ziping, Zou, Fengming, Liu, Feiyang, Hu, Jie, Zhao, Ming, Huang, Tao, Wang, Beilei, Wang, Li, Wang, Wei, Wang, Wenchao, Ren, Tao, Liu, Jing, Sun, Yehuan, Fan, Song, Wu, Qibing, Liang, Chaozhao, Sun, Liangdan, Su, Bin, Wei, Wei, Liu, Qingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700809/
https://www.ncbi.nlm.nih.gov/pubmed/34765997
http://dx.doi.org/10.1186/s43556-020-00018-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700809/
https://www.ncbi.nlm.nih.gov/pubmed/34765997
http://dx.doi.org/10.1186/s43556-020-00018-9

Ejemplares similares